What's in Tibotec, Inc's pipeline?

Tibotec, Inc has 2 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Tibotec, Inc's portfolio?

Top competitors by shared drug class: Bristol-Myers Squibb, ViiV Healthcare, GlaxoSmithKline, Baqiyatallah Medical Sciences University, Drugs for Neglected Diseases.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/tibotec-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Tibotec, Inc — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tibotec, Inc pipeline: 1 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
emtricitabine [FTC]/tenofovir [TDF]	emtricitabine [FTC]/tenofovir [TDF]	marketed	Nucleoside reverse transcriptase inhibitor (NRTI) combination	HIV reverse transcriptase	Infectious Disease / Virology
TMC125, Darunavir; Ritonavir	TMC125, Darunavir; Ritonavir	phase 3	HIV protease inhibitor	HIV protease	Infectious Diseases

Therapeutic area mix

Infectious Disease / Virology · 1
Infectious Diseases · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bristol-Myers Squibb · 2 shared drug classes
ViiV Healthcare · 2 shared drug classes
GlaxoSmithKline · 2 shared drug classes
Baqiyatallah Medical Sciences University · 1 shared drug class
Drugs for Neglected Diseases · 1 shared drug class
DualityBio Inc. · 1 shared drug class
Community Research Initiative of New England · 1 shared drug class
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Tibotec, Inc:

Cite this brief

Drug Landscape (2026). Tibotec, Inc — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/tibotec-inc. Accessed 2026-06-10.